How do #breastcancer susceptibility genes, polygenic risk score (PRS) and family history impact the risk of breast cancer over the life course?

With @ninjmars, we tested this in @FinnGen_FI in 120,000 women:

https://www.nature.com/articles/s41467-020-19966-5

@NatureComms @fimm_uh @CoECDG
First, we developed a new genome-wide PRS, which outperformed previously published PRSs.

In line with previous studies on breast cancer and several other common diseases, genome-wide scores outperformed PRSs containing a smaller number of variants.

2/7
We took carriers of two important frameshift variants in PALB2 and CHEK2 and compared their lifetime risks with women in the top decile of the polygenic risk score.

Women with a high PRS had a lifetime risk of 33%, at least similar to that conferred by CHEK2.

3/7
The relative risks for the PRS were similar in mutation carriers and in non-carriers. The PRS modified the risk considerably in both CHEK2 and PALB2 mutation carriers, e.g. CHEK2 and a PRS in the protective tail conferred a lifetime risk lower than the population average.

4/7
We show that women diagnosed with breast cancer who have a PRS in the top decile had a 1.6-fold elevated risk for contralateral breast cancer. Moreover, we show that PRS could considerably improve breast cancer risk assessment of their first-degree relatives.

5/7
Our study highlights opportunities arising from comprehensive assessment of genetic risk in the population, in breast cancer patients, and in unaffected family members.

6/7
The work was done by a terrific team @ninajmars, Elisabeth Widén, @SiniKerminen, Tuomo Meretoja, @APalotie, @JKaprio, Heikki Joensuu, @dalygene and many others.

We are grateful for the amazing @FinnGen_FI community, the biobanks, Finns who have donated samples.

7/7
Apologies, the correct Twitter handle for Nina Mars is of course @ninajmars. Now go follow her.
You can follow @samrip.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.